Who can use Pulmozyme(Dornase Alfa)?

1. Pulmozyme is indicated for the treatment of pediatric and adult patients with cystic fibrosis (CF) in combination with standard therapy to improve lung function.

2. In patients with CF with FVC ≥ 40% predicted, daily administration of Pulmozyme has also been shown to reduce the risk of respiratory infections requiring parenteral antibiotics.

Dornase Alfa(Pulmozyme)
Pulmozyme is indicated for inhalation in children and adults with cystic fibrosis (CF) in combination with standard therapy to improve lung function.
RELATED ARTICLES
Dosage of Dornase Alfa(Pulmozyme)

Pulmozyme is a core drug for the treatment of decreased lung function in patients with cystic fibrosis (CF). Its...

Monday, July 7th, 2025, 13:29
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved